Yield10 Third Quarter 2022 Financial Results and Business Highlights Today Nov. 14, 2022 Yield10 Bioscience, Inc. www.yield10bio.com NASDAQ: YTEN Sustainable Growth Starts with a Seed Safe Harbor Statement* Today 2 The statements made by Yield10 Bioscience, Inc. (the "Company," "we," "our" or "us") herein regarding the Company and its business may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statemen ...

Yield10 Bioscience, Inc. (OTCQB:YTEN) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Lynne Brum - VP, Planning & Corporate Communications & Secretary Oliver Peoples - Co-Founder, President, CEO & Director Kristi Snell - VP, & Chief Science Officer Charles Haaser - VP, Finance, CAO & Treasurer Conference Call Participants Anthony Vendetti - Maxim Group Benjamin Klieve - Lake Street Capital Markets Sameer Joshi - H.C. Wainwright & Co. Operator Welcome to the second quarter 20 ...

Yield10 Yield10 Bioscience, Inc. www.yield10bio.com NASDAQ: YTEN Second Quarter 2022 Financial Results and Business Highlights Today Aug. 10, 2022 Sustainable Growth Starts with a Seed Safe Harbor Statement* Today 2 The statements made by Yield10 Bioscience, Inc. (the "Company," "we," "our" or "us") herein regarding the Company and its business may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking stateme ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33133 YIELD10 BIOSCIENCE, INC. (State or other jurisdiction of incorporation or organization) 19 Presidential Way Woburn, MA 01801 (Address ...

Yield10 Bioscience, Inc. (OTCQB:YTEN) Q1 2022 Results Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Lynne Brum - Vice President, Planning and Corporate Communications Oliver Peoples - President and Chief Executive Officer Kristi Snell - Vice President, Research and Chief Science Officer Charles Haaser - Vice President, Finance and Chief Accounting Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Anthony Vendetti - Maxim Group Michael Irwin - Univest Secur ...

Yield10 First Quarter 2022 Financial Results and Business Highlights Today May 11, 2022 Yield10 Bioscience, Inc. www.yield10bio.com NASDAQ: YTEN Sustainable Growth Starts with a Seed Safe Harbor Statement* Today 2 The statements made by Yield10 Bioscience, Inc. (the "Company," "we," "our" or "us") herein regarding the Company and its business may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statement ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33133 YIELD10 BIOSCIENCE, INC. (State or other jurisdiction of incorporation or organization) 19 Presidential Way Woburn, MA 01801 (Addres ...

40Use these links to rapidly review the document TABLE OF CONTENTS Index to Consolidated Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-33133 YIELD10 BIOSCIENCE, INC. (Exact name of registrant as specifie ...

Yield10 Yield10 Bioscience, Inc. www.yield10bio.com NASDAQ: YTEN Fourth Quarter and Full Year 2021 Financial Results and Business Highlights Today March 09, 2022 Sustainable Growth Starts with a Seed Safe Harbor Statement* Today 2 The statements made by Yield10 Bioscience, Inc. (the "Company," "we," "our" or "us") herein regarding the Company and its business may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward- ...

Yield10 Bioscience, Inc. (OTCQB:YTEN) Q4 2021 Earnings Conference Call March 9, 2022 4:30 PM ET Company Participants Lynne Brum - VP, Planning & Corporate Communications and Secretary Oliver Peoples - Co-Founder, President, CEO & Director Kristi Snell - VP, Research & Chief Science Officer Conference Call Participants Anthony Vendetti - Maxim Group Sameer Joshi - H.C. Wainwright & Co. Operator Welcome to the Fourth Quarter and Full Year 2021 Financial Results and Business Update Conference Call for Yield10 ...